Yarbrough Capital’s Thermo Fisher Scientific TMO Stock Holding History

Yarbrough Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-742	Closed	-$430K	–	144
2025 Q4	$430K	Hold	742	–	–	0.01%	122
2025 Q3	$360K	Buy	+742	New	+$345K	0.01%	140
2024 Q4	–	Sell	-2,000	Closed	-$1.24M	–	212
2024 Q3	$1.24M	Hold	2,000	–	–	0.05%	82
2024 Q2	$1.11M	Hold	2,000	–	–	0.05%	85
2024 Q1	$1.16M	Hold	2,000	–	–	0.05%	86
2023 Q4	$1.06M	Hold	2,000	–	–	0.06%	90
2023 Q3	$1.01M	Hold	2,000	–	–	0.06%	92
2023 Q2	$1.04M	Hold	2,000	–	–	0.06%	91
2023 Q1	$1.15M	Hold	2,000	–	–	0.09%	87
2022 Q4	$1.1M	Hold	2,000	–	–	0.09%	78
2022 Q3	$1.01M	Hold	2,000	–	–	0.08%	83
2022 Q2	$1.09M	Hold	2,000	–	–	0.08%	81
2022 Q1	$1.18M	Hold	2,000	–	–	0.07%	94
2021 Q4	$1.33M	Buy	+2,000	New	+$1.25M	0.07%	102

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Yarbrough Capital's TMO Position: Q1 2026 in Review

Yarbrough Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 742 shares — an estimated $430K sold.

Yarbrough Capital first reported a position in TMO in Q4 2021 and held it in 14 quarters. The position peaked at $1.33M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Yarbrough Capital reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Yarbrough Capital sold 742 Thermo Fisher Scientific shares in Q1 2026, an estimated $430K.
Yarbrough Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 14 quarters.
Yarbrough Capital's Thermo Fisher Scientific position peaked at $1.33M in Q4 2021.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Yarbrough Capital's 13F filing for Q1 2026, filed 14 Apr 2026.